FSWD:LSE:LSE-iShares Edge MSCI World Multifactor UCITS ETF USD (Acc) GBP (GBX)

ETF | Others |

Last Closing

USD 919.25

Change

0.00 (0.00)%

Market Cap

N/A

Volume

0.02M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-02 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNIF:LSE Xtrackers Nifty 50 Swap UCITS ..

N/A

USD 292,109.69B
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

N/A

USD 292,109.69B
0R1O:LSE Amazon.com Inc.

N/A

USD 1,607.29B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

N/A

USD 701.81B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

N/A

USD 636.56B
0R1I:LSE NVIDIA Corp.

N/A

USD 618.20B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

N/A

USD 266.08B
PRJU:LSE Amundi Index Solutions - Amund..

N/A

USD 260.39B
0QZO:LSE 0QZO

N/A

USD 258.54B

ETFs Containing FSWD:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.42% 64% D 59% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.42% 63% D 58% F
Trailing 12 Months  
Capital Gain 13.79% 74% C 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.79% 73% C 69% C-
Trailing 5 Years  
Capital Gain 70.78% 74% C 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 70.78% 72% C 78% C+
Average Annual (5 Year Horizon)  
Capital Gain 12.11% 68% D+ 71% C-
Dividend Return 12.11% 67% D+ 70% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 10.63% 66% D+ 80% B-
Risk Adjusted Return 113.86% 94% A 96% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike